PURPOSE: To determine quantitatively a possible corpus callosum (CC) involvement in normal aging and white matter diseases. METHODS: Midsagittal size and signal of CC were recorded prospectively from 243 routine MR brain examinations. A midline internal skull surface (MISS) and subcutaneous fat signal intensity were measured to calculate CC/MISS and CC/fat ratios. Four groups of subjects were studied: 124 apparently healthy subjects, 45 patients with multiple sclerosis, 13 patients with a noncerebral cancer under chemotherapy, and 37 AIDS patients. RESULTS: Mean surface area of CC in controls was 6.36 cm2. It was significantly larger in men than in women (P < .05), but CC/MISS ratio was not. Elderly controls > 70 years and AIDS patients displayed significant CC atrophy, as well as multiple sclerosis subjects with long-standing disease or with a severe chronic progressive form. CONCLUSION: CC substance loss identification should not be based on visual inspection or on absolute area, but by means of a CC/MISS ratio.
PURPOSE: To determine quantitatively a possible corpus callosum (CC) involvement in normal aging and white matter diseases. METHODS: Midsagittal size and signal of CC were recorded prospectively from 243 routine MR brain examinations. A midline internal skull surface (MISS) and subcutaneous fat signal intensity were measured to calculate CC/MISS and CC/fat ratios. Four groups of subjects were studied: 124 apparently healthy subjects, 45 patients with multiple sclerosis, 13 patients with a noncerebral cancer under chemotherapy, and 37 AIDSpatients. RESULTS: Mean surface area of CC in controls was 6.36 cm2. It was significantly larger in men than in women (P < .05), but CC/MISS ratio was not. Elderly controls > 70 years and AIDSpatients displayed significant CC atrophy, as well as multiple sclerosis subjects with long-standing disease or with a severe chronic progressive form. CONCLUSION: CC substance loss identification should not be based on visual inspection or on absolute area, but by means of a CC/MISS ratio.
Authors: E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux Journal: AJNR Am J Neuroradiol Date: 2001-01 Impact factor: 3.825
Authors: Khader M Hasan; David L Molfese; Indika S Walimuni; Karla K Stuebing; Andrew C Papanicolaou; Ponnada A Narayana; Jack M Fletcher Journal: NMR Biomed Date: 2012-03-13 Impact factor: 4.044
Authors: E Hofmann; T Becker; M Jackel; D Metzner; M Schneider; J Meixensberger; H Reichmann Journal: Neuroradiology Date: 1995-04 Impact factor: 2.804
Authors: M Takaoka; H Tabuse; E Kumura; S Nakajima; T Tsuzuki; K Nakamura; A Okada; H Sugimoto Journal: J Neurol Neurosurg Psychiatry Date: 2002-09 Impact factor: 10.154
Authors: Tejal N Mitchell; Samantha L Free; Martin Merschhemke; Louis Lemieux; Sanjay M Sisodiya; Simon D Shorvon Journal: AJNR Am J Neuroradiol Date: 2003-03 Impact factor: 3.825
Authors: H Yamauchi; M Pagani; H Fukuyama; Y Ouchi; Y Nagahama; S Matsuzaki; J Kimura; Y Yonekura; J Konishi Journal: J Neurol Neurosurg Psychiatry Date: 1995-10 Impact factor: 10.154